FindTrial
Sign In

no

- no

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-001143-70-ES
Enrollment
Unknown
Registered
2011-09-15
Start date
2011-06-30
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.0 Level: HLGT Classification code 10035227 Term: Plasma cell neoplasms System Organ Class: 10005329 - Blood and lymphatic system disorders

Interventions

Trade Name: HYDRAPRES 50 mg comprimidos Pharmaceutical Form: Tablet INN or Proposed INN: HIDRALAZINA HIDROCLORURO CAS Number: 304-20-1 Other descriptive name: HYDRALAZINE HYDROCHLORIDE Concentration u

Sponsors

Breno Moreno de Gusmao
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 84 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s): ;Timepoint(s) of evaluation of this end point: no—

Secondary

MeasureTime frame
Secondary end point(s): no;Timepoint(s) of evaluation of this end point: no—

Countries

Spain

Contacts

Public Contactno

no

non0nono

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026